This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Normothermia Protocol for Traumatic Brain Injury Patients

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified May 2011 by Medivance, Inc..
Recruitment status was:  Recruiting
Information provided by:
Medivance, Inc. Identifier:
First received: May 12, 2011
Last updated: May 17, 2011
Last verified: May 2011

Comparison between a normothermia protocol and current protocol (acetaminophen plus blankets)

  1. Normothermia Protocol is successful in achieving and maintaining normal temperature in moderate to severe Traumatic Brain Injury (TBI) patients.(using Arctic Sun for 96 hrs from admission to Neuro ICU)
  2. Normothermia is translated into improved neurologic Outcome and survival compared to standard of care (Physician management)

Traumatic Brain Injury

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Normothermia Protocol for Traumatic Brain Injury Patients: An Outcome Study

Resource links provided by NLM:

Further study details as provided by Medivance, Inc.:

Primary Outcome Measures:
  • Effectiveness of the Normothermia protocol [ Time Frame: 5 days ]
    Number of times patient's temp was above 37°C during this 96 hr period

  • Temperature vs ICP [ Time Frame: 5 days ]
    Number of times ICP > 20 in patients with ICP monitors

  • Neurologic Outcome of the 2 patient populations [ Time Frame: 1month, 3 months, 6 months ]
    Modified Rankin Scale at Hospital discharge, 3 months, and 6 months

Secondary Outcome Measures:
  • Mortality [ Time Frame: 5 days, 3 months, 6 months ]
    In-Hospital mortality, 3 - 6 month mortality

Estimated Enrollment: 80
Study Start Date: May 2011
Estimated Study Completion Date: May 2013
Estimated Primary Completion Date: May 2012 (Final data collection date for primary outcome measure)
Current protocol group
Patients treated with current standards based on physician discretion.
Normothermia group
Normothermia protocol, using Hydrogel cooling Pads(Arctic Sun) applied for 96 hrs starting upon admission to the ICU


Ages Eligible for Study:   18 Years to 85 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Severe TBI patients(GCS 3-9) admitted to ICU

Inclusion Criteria:

  • Severe TBI patients(GCS 3-9) admitted to ICU

Exclusion Criteria:

  • Less than 18 years OLD.
  • Bleeding disorders.
  • Pregnancy/Breastfeeding.
  • Hepatic Encephalopathy.
  • Spinal cord injury (know or new)
  • Fever >100 F prior to randomization.
  • Blood Alcohol level >80
  • Participation in other Research trial.
  • Inability/unwilling to obtain Informed consent.
  • Terminal illness(not expected to survive 3-6 months)
  • Not expected to survive 24 hrs.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01354509

Contact: Farid Sadaka, MD 214-251-6486
Contact: Catherine Krause, RN 314-251-5653

United States, Missouri
Mercy St John's Medical Center Recruiting
St Louis, Missouri, United States, 63141
Contact: Farid Sadaka, MD    214-251-6486   
Contact: Catherine Krause, RN    314-251-5653   
Sponsors and Collaborators
Medivance, Inc.
Principal Investigator: Farid Sadaka, MD Mercy St John's Medical Center
  More Information

Responsible Party: Farid Sadaka, MD, Mercy St John's Medical Center Identifier: NCT01354509     History of Changes
Other Study ID Numbers: MDV_STL_001
Study First Received: May 12, 2011
Last Updated: May 17, 2011

Keywords provided by Medivance, Inc.:
fever control
Outcome study

Additional relevant MeSH terms:
Wounds and Injuries
Brain Injuries
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Craniocerebral Trauma
Trauma, Nervous System processed this record on August 21, 2017